SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
DXR

Daxor Corp (NASDAQ:DXR)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$7.45-$0.59 (-7.33%)
 
Market cap
$43.5M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 25, 1983
Website
Market Cap$43.49M-43.8%
Revenue (ttm)$154.87K+161.9%
Net Income$6.23M+42.3%
EPS$1.23+118.6%
Shares Out5.84M
PE Ratio6.06
Forward PEn/a
Dividendn/a
Ex-Dividend DateJan 5, 2018
Volume33,829
Open$7.82
Previous Close$8.04
Day's Range$7.00 - $7.88
52-Week Range$6.94 - $14.76
Beta0.26
AnalystsBuy
Price Target$23.00(+208.72%)
Earnings DateMar 10, 2027
-7.33% (1D)
No price history available.

About DXR

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.

Address
109 Meco Lane, Oak Ridge, TN, 37830, US
Market Cap
43 million
Employees
37
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$27.00K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From DXR’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-7.33%
5 Days
-12.35%
1 Month
-20.74%
6 Months
-31.15%
1 Year
-43.77%

$DXR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in DXR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by DXR's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

DXR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New DXR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to DXR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in DXR

VTIVanguard Morningstar Total Stock Market ETF$345.18K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from DXR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
73.71
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
8
Sells
0
Buy Value
$27.00K
Distinct Buyers
4

Insider Score Trend Over Time

-0.4 since Nov 20
0255075100Nov 20 — Insider Score 74.1Nov 21 — Insider Score 73.3Nov 22 — Insider Score 73.7Nov 20Nov 21Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.